CNSX:CALIFincanna Capital Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Fincanna Capital Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.09 0.00 (0.00 %) (As of 05/29/2020 04:00 PM ET) Add Compare Share Today's Range$0.09Now: $0.09▼$0.0950-Day Range N/A52-Week Range N/AVolume94,000 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlines FinCanna Capital Corp. operates as a royalty investment company for the licensed medical cannabis industry in the United States. The company provides financing to top-tier companies in the licensed medical cannabis industry in exchange for a royalty on revenues with a focus on California. The company has royalty agreements with Cultivation Technologies Inc.; Green Compliance Inc.; and Refined Resin Technologies Inc. FinCanna Capital Corp. is headquartered in Vancouver, Canada.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingFincanna Capital has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $0.29, Fincanna Capital has a potential upside of 222.2% from its current price of $0.09.Amount of Analyst CoverageFincanna Capital has only been the subject of 1 research reports in the past 90 days. Previous Next 2.9 Community Rank Outperform VotesFincanna Capital has received 12 “outperform” votes. (Add your “outperform” vote.)Underperform VotesFincanna Capital has received 9 “underperform” votes. (Add your “underperform” vote.)Community SentimentFincanna Capital has received 57.14% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Fincanna Capital and other stocks. Vote “Outperform” if you believe CALI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CALI will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldFincanna Capital does not currently pay a dividend.Dividend GrowthFincanna Capital does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Fincanna Capital insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.5Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.28 out of 5 stars Industry, Sector and Symbol Stock Exchange CNSX Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCNSX:CALI Previous Symbol CUSIPN/A CIKN/A Webwww.fincannacapital.com Phone778-327-5799Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable TSXV:CALI Rates by TradingView Receive CALI News and Ratings via Email Sign-up to receive the latest news and ratings for CALI and its competitors with MarketBeat's FREE daily newsletter. Fincanna Capital (CNSX:CALI) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of Fincanna Capital? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fincanna Capital in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Fincanna Capital. What price target have analysts set for CALI? 1 Wall Street analysts have issued 1 year price targets for Fincanna Capital's stock. Their forecasts range from $0.29 to $0.29. On average, they expect Fincanna Capital's stock price to reach $0.29 in the next twelve months. This suggests a possible upside of 222.2% from the stock's current price. View analysts' price targets for Fincanna Capital. Has Fincanna Capital been receiving favorable news coverage? Headlines about CALI stock have trended very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Fincanna Capital earned a coverage optimism score of -3.0 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View the latest news aboutFincanna Capital. Who are some of Fincanna Capital's key competitors? Some companies that are related to Fincanna Capital include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF). View all competitors. Who are Fincanna Capital's key executives? Fincanna Capital's management team includes the following people: Mr. Andriyko Taras Herchak B.Com., C.A., CPA, CA, Pres, CEO & Director (Age 47)Mr. Robert James Scott, CFO & DirectorMr. Jeffrey Dare, Corp. Sec. & Director (Age 39) What is Fincanna Capital's stock symbol? Fincanna Capital trades on the CNSX under the ticker symbol "CALI." How do I buy shares of Fincanna Capital? Shares of CALI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Fincanna Capital's stock price today? One share of CALI stock can currently be purchased for approximately $0.09. What is Fincanna Capital's official website? The official website for Fincanna Capital is www.fincannacapital.com. How can I contact Fincanna Capital? The company can be reached via phone at 778-327-5799. This page was last updated on 5/31/2020 by MarketBeat.com Staff
